These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 2209086
1. The human tyrosine kinase gene (FER) maps to chromosome 5 and is deleted in myeloid leukemias with a del(5q). Morris C, Heisterkamp N, Hao QL, Testa JR, Groffen J. Cytogenet Cell Genet; 1990; 53(4):196-200. PubMed ID: 2209086 [Abstract] [Full Text] [Related]
2. The interleukin 3 gene is located on human chromosome 5 and is deleted in myeloid leukemias with a deletion of 5q. Le Beau MM, Epstein ND, O'Brien SJ, Nienhuis AW, Yang YC, Clark SC, Rowley JD. Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5913-7. PubMed ID: 3497400 [Abstract] [Full Text] [Related]
3. Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q). Le Beau MM, Lemons RS, Espinosa R, Larson RA, Arai N, Rowley JD. Blood; 1989 Feb 15; 73(3):647-50. PubMed ID: 2783863 [Abstract] [Full Text] [Related]
4. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Le Beau MM, Espinosa R, Neuman WL, Stock W, Roulston D, Larson RA, Keinanen M, Westbrook CA. Proc Natl Acad Sci U S A; 1993 Jun 15; 90(12):5484-8. PubMed ID: 8516290 [Abstract] [Full Text] [Related]
5. Deletions of chromosome 5 in malignant myeloid disorders. Le Beau MM. Cancer Surv; 1992 Jun 15; 15():143-59. PubMed ID: 1451109 [Abstract] [Full Text] [Related]
6. Characterization and phylogenetic analysis of a cDNA encoding the Fes/FER related, non-receptor protein-tyrosine kinase in the marine sponge sycon raphanus. Cetkovic H, Müller IM, Müller WE, Gamulin V. Gene; 1998 Aug 17; 216(1):77-84. PubMed ID: 9714748 [Abstract] [Full Text] [Related]
7. The FER gene is evolutionarily conserved and encodes a widely expressed member of the FPS/FES protein-tyrosine kinase family. Pawson T, Letwin K, Lee T, Hao QL, Heisterkamp N, Groffen J. Mol Cell Biol; 1989 Dec 17; 9(12):5722-5. PubMed ID: 2685575 [Abstract] [Full Text] [Related]
8. FES/FER kinase signaling in hematopoietic cells and leukemias. Craig AW. Front Biosci (Landmark Ed); 2012 Jan 01; 17(3):861-75. PubMed ID: 22201778 [Abstract] [Full Text] [Related]
9. c-src is consistently conserved in the chromosomal deletion (20q) observed in myeloid disorders. Le Beau MM, Westbrook CA, Diaz MO, Rowley JD. Proc Natl Acad Sci U S A; 1985 Oct 01; 82(19):6692-6. PubMed ID: 2413444 [Abstract] [Full Text] [Related]
10. Assignment of CSF-1 to 5q33.1: evidence for clustering of genes regulating hematopoiesis and for their involvement in the deletion of the long arm of chromosome 5 in myeloid disorders. Pettenati MJ, Le Beau MM, Lemons RS, Shima EA, Kawasaki ES, Larson RA, Sherr CJ, Diaz MO, Rowley JD. Proc Natl Acad Sci U S A; 1987 May 01; 84(9):2970-4. PubMed ID: 3495006 [Abstract] [Full Text] [Related]
11. Anatomy of the 5q- deletion: different sex ratios and deleted 5q bands in MDS and AML. Pedersen B. Leukemia; 1996 Dec 01; 10(12):1883-90. PubMed ID: 8946926 [Abstract] [Full Text] [Related]
12. Regulation of the human c-fes protein tyrosine kinase (p93c-fes) by its src homology 2 domain and major autophosphorylation site (Tyr-713). Hjermstad SJ, Peters KL, Briggs SD, Glazer RI, Smithgall TE. Oncogene; 1993 Aug 01; 8(8):2283-92. PubMed ID: 7687763 [Abstract] [Full Text] [Related]
13. Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders. Le Beau MM, Westbrook CA, Diaz MO, Larson RA, Rowley JD, Gasson JC, Golde DW, Sherr CJ. Science; 1986 Feb 28; 231(4741):984-7. PubMed ID: 3484837 [Abstract] [Full Text] [Related]
14. FES kinases are required for oncogenic FLT3 signaling. Voisset E, Lopez S, Chaix A, Georges C, Hanssens K, Prébet T, Dubreuil P, De Sepulveda P. Leukemia; 2010 Apr 28; 24(4):721-8. PubMed ID: 20111072 [Abstract] [Full Text] [Related]
15. Cytogenetic features of 5q deletion and 5q- syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization. Lee HR, Oh B, Hong DS, Zang DY, Yoon HJ, Kim HJ, Kim I, Ahn JS, Cheong JW, Lee KA, Cho KS, Lee MH, Bang SM, Kim TY, Yun YM, Min YH, Lee YK, Lee DS, AML/MDS Working Party of the Korean Society of Hematology. Cancer Genet Cytogenet; 2010 Dec 28; 203(2):193-202. PubMed ID: 21156233 [Abstract] [Full Text] [Related]
16. The c-Fes family of protein-tyrosine kinases. Smithgall TE, Rogers JA, Peters KL, Li J, Briggs SD, Lionberger JM, Cheng H, Shibata A, Scholtz B, Schreiner S, Dunham N. Crit Rev Oncog; 1998 Dec 28; 9(1):43-62. PubMed ID: 9754447 [Abstract] [Full Text] [Related]
17. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase. Rogers JA, Cheng HY, Smithgall TE. Cell Growth Differ; 2000 Nov 28; 11(11):581-92. PubMed ID: 11095247 [Abstract] [Full Text] [Related]
18. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation. Liu TX, Becker MW, Jelinek J, Wu WS, Deng M, Mikhalkevich N, Hsu K, Bloomfield CD, Stone RM, DeAngelo DJ, Galinsky IA, Issa JP, Clarke MF, Look AT. Nat Med; 2007 Jan 28; 13(1):78-83. PubMed ID: 17159988 [Abstract] [Full Text] [Related]
19. Deletion of c-fms sequences in the 5q- syndrome. Bartram CR, Böhlke JV, Adolph S, Hameister H, Ganser A, Anger B, Heisterkamp N, Groffen J. Leukemia; 1987 Feb 28; 1(2):146-9. PubMed ID: 3312836 [Abstract] [Full Text] [Related]
20. Localization of the human IL-2-inducible T-cell kinase gene (ITK) to chromosome band 5q34 and the mouse gene (Itk) to chromosome 15 by fluorescence in situ hybridization. Tate G, Okuyama M, Okamoto M, Futaki G, Kimura S, Endo Y, Mitsuya T, Katagiri M. Cytogenet Cell Genet; 1996 Feb 28; 74(1-2):96-8. PubMed ID: 8893810 [Abstract] [Full Text] [Related] Page: [Next] [New Search]